Thu, Oct 2, 2014, 6:35 AM EDT - U.S. Markets open in 2 hrs 55 mins


% | $
Quotes you view appear here for quick access.

Galectin Therapeutics, Inc. Message Board

  • dr.vinmantoo dr.vinmantoo Jun 21, 2012 4:48 PM Flag

    How about that ONXX!!

    Remember that the lying ignorant pumper novelshe was saying ONXX was a POS when it was in the low $30s and upper $20s. I laughed at him bought more.

    Well, ONXX surged by more than 40% today or ~$20/share to close at almost $64/share. Obviously as an ONXX long I am pleased by the big stock price surge today.

    Remember when Az was calling ONXX a POS and was spouting off that Bayer would crush ONXX when ONXX sued Bayer over Regorafenib. I laughed at AZ and brought more ONXX. Well, ONXX won the lawsuit by forcing Bayer to settle and give ONXX of the Regorafenib world-wide. Regorafenib will be approved in GIST and possibly even in 4th line metastatic colon cancer for starters.

    I never understood what Bayer was thinking after they were forced to settled with ONXX and give them 20% of the Regorafenib revenues. I figured that settlement would make them buy ONXX since they probably could have bought ONXX for $50/share. If they are still interested, the buyout price has gone way, way up. I don't think that $100/share is out of the question now.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
4.84-0.19(-3.78%)Oct 1 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.